Wucherpfennig K W, Zhang J, Witek C, Matsui M, Modabber Y, Ota K, Hafler D A
Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA.
J Immunol. 1994 Jun 1;152(11):5581-92.
TCR rearrangements were used to probe the clonal origin of myelin basic protein (MBP)-reactive T cells from patients with multiple sclerosis (n = 7) and normal subjects (n = 3). The majority of MBP-specific T cell lines were specific for the immunodominant MBP(84-102) and MBP(143-168) peptides and were restricted by HLA-DR molecules. In two patients with the DR2 haplotype, the T cell response to MBP was focused on the MBP(84-102) peptide. In both patients, in vivo expanded population(s) (three expanded populations in the first patient, one expanded population in the second patient) dominated the response to the MBP(84-102) peptide. Two MBP(84-102)-specific T cell clones from a normal subject with the DR2 haplotype were also found to have identical TCR sequences. Clonality was proven by demonstrating that independent clones had identical TCR alpha- and TCR beta-chain sequences as well as identical sequences of a TCR gamma-chain or of a second TCR alpha-chain rearrangement. Repeated analysis of one patient after 13 mo demonstrated that the three expanded clones had persisted in vivo. A representative of one of the expanded clones was again obtained after 31 mo by IL-2 stimulation suggesting that this clone was activated in vivo. These data suggest that the response to human MBP is dominated in at least some subjects by expanded clones that may persist in vivo for relatively long periods of time.
采用TCR重排来探究来自多发性硬化症患者(n = 7)和正常受试者(n = 3)的髓鞘碱性蛋白(MBP)反应性T细胞的克隆起源。大多数MBP特异性T细胞系对免疫显性的MBP(84 - 102)和MBP(143 - 168)肽具有特异性,并受HLA - DR分子限制。在两名具有DR2单倍型的患者中,对MBP的T细胞反应集中在MBP(84 - 102)肽上。在这两名患者中,体内扩增的群体(第一名患者中有三个扩增群体,第二名患者中有一个扩增群体)主导了对MBP(84 - 102)肽的反应。还发现来自一名具有DR2单倍型的正常受试者的两个MBP(84 - 102)特异性T细胞克隆具有相同的TCR序列。通过证明独立克隆具有相同的TCRα链和TCRβ链序列以及相同的TCRγ链序列或第二个TCRα链重排序列来证实克隆性。对一名患者在13个月后进行的重复分析表明,这三个扩增的克隆在体内持续存在。31个月后通过IL - 2刺激再次获得其中一个扩增克隆的代表,表明该克隆在体内被激活。这些数据表明,在至少一些受试者中,对人MBP的反应由可能在体内持续相对较长时间的扩增克隆主导。